MedTrace Logo

The Effect of N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis

NCT01587001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2020-11-04

Study results available
· View outcomes & findings →

Summary

This is a pilot study investigating the effect of an antioxidant, N-Acetyl-L-Cysteine (NAC), on inflammation and oxidative stress in sarcoidosis.

Conditions

  • Pulmonary Sarcoidosis

Interventions

DIETARY_SUPPLEMENT

N-acetyl-cysteine

900mg three times daily for 8 weeks

DRUG

Placebo

Matching placebo three times daily for 8 weeks.

Sponsors & Collaborators

  • American Thoracic Society

    collaborator OTHER

  • National Jewish Health

    lead OTHER

Principal Investigators

  • Nabeel Hamzeh, MD · National Jewish Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01587001 on ClinicalTrials.gov